The therapeutic potential of anti-cytokine strategies in central nervous system ischaemia

Bibliography

• BENVENISTE EN: Inflammatory cytokines within the central nervous system: sources, function, and mecha-nism of action. Am. J. Physiol. (1992) 263:C1–16.
   Web of Science ®Google Scholar
• FEUERSTEIN GZ, WANG X, YUE TL, BARONE FC: Inflammatory cytokines and stroke: emerging new strategies for stroke therapeutics. In: Cerebrovascular Diseases: Nineteenth Princeton Stroke Conference. Moskowitz MA, Caplan LR (Eds.), Butterworth-Heinemann, Newton, MA (1995):75–91. Good review of topic.
   Google Scholar
• MINAMI M, KURAISHI Y, YABUUCHI K, YAMAZAKI A,SATOH M: Induction of interleukin-1I3 mRNA in rat brain after transient forebrain ischemia. j Neurochem. (1991) 58:390–392.
   Web of Science ®Google Scholar
• FASSBENDER K, ROSSOL S, KAMMER T et al.: Proinflammatory cytokines in serum of patients with acute cere-bral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. Neurol ScL (1994) 122:135-139. Measures acute cytokine changes following clinical stroke.
   Google Scholar
• TARKOWSKI E, ROSENGREN L, BLOMSTRAND C et al.:
   Google Scholar
• •Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 26:1393-1398. Demonstrates the relationship between CSF IL-6 and final infarct size.
   Google Scholar
• CHUNG IL, BENVENISTE EN: Tumor necrosis factor pro-duction by astrocytes: induction by lipoplysacharide, IFN-y, and IL-113. j Immunol (1990) 144:2999–3007.
   PubMed Web of Science ®Google Scholar
• LUI T, YOUNG PR, MCDONNELL et al.: Cytokine-induced neutrophil chemoattractant mRNA expressed in cere-bral ischemia. Neurosci. Lett. (1993) 164:125–128.
   PubMed Web of Science ®Google Scholar
• KIM JS, GAUTAM SC, CHOPP M et al: Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. (1995) 56:127-134a.
   Google Scholar
• KIM JS: Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. (1996) 137:69-78. Brief overview of area.
   Google Scholar
• KOCHANEK PM, HALLENBECK JM: Polymorphonuclear leukocytes and monocytes/macrophages in the patho-genesis of cerebral ischemia and stroke. Stroke (1992) 23:1367–1379.
   PubMed Web of Science ®Google Scholar
• CLARK WM, MADDEN KP, ROTHLEIN R, ZIVIN JA: Reduc-tion of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion mole-cule. J. Neurosurg. (1991) 75:623–627.
   PubMed Web of Science ®Google Scholar
• CLARK WM, MADDEN KP, ROTHLEIN R, ZIVIN JA: Reduc-tion of central nervous system ischemic injury in rab-bits using leukocyte adhesion antibody treatment. Stroke (1991) 22:877–883.
   PubMed Web of Science ®Google Scholar
• SET Y, VITKOVIC L, YOKOYAMA MM: Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodula-don (1995) 2:121–133.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA, GELFAND JA, WOLFF SM: Anticytokine strategies in the treatment of the systemic inflamma-tory response syndrome. JAMA (1993) 269:1829–1835.
   PubMed Web of Science ®Google Scholar
• ALOISI F, CAR F, BORSELLINO G et al: Production of hemolymphopoietic cytokines (11-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1I3 and tumor necrosis factor-cc. J. Immu-nol (1992) 149:2358–2366.
   PubMed Web of Science ®Google Scholar
• SELMAJ K, FAROOQ M, NORTON WT, RAINE CS, BROSNAN CF: Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J. Immunol (1990) 144:129–135.
   PubMed Web of Science ®Google Scholar
• FISHER C, SLOTMAN GJ, OPAL S: Interleukin-1 receptorantagonist reduces mortality in patients with sepsis syndrome. Fourth Annual Meeting of the American College of Chest Physicians. San Francisco, California (November 4, 1991).
   Google Scholar
• MCCARTHY PL, ABHYANKAR S, NEBEN S et aL: Inhibitionof interleukin-1 by interleukin-1 receptor antagonist prevents graft versus host disease. Blood (1991) 78: 1915-1918.
   Google Scholar
• OHLSSON K, BJORK P, BERGENFELDT M, HAGEMAN R,THOMPSON RC: Interleukin-1 receptor antagonist re-duces mortality from endotoxin shock. Nature (1990) 348:550–552.
   PubMed Web of Science ®Google Scholar
• AIURA K, GELFAND JA, WAKABAYASHI G: Interleukin-1 receptor antagonist blocks staphylococcal induced shock in rabbits. Cytokine (1991) 3:498.
   Google Scholar
• GERSHENWALD JE, FONG YM, FAHEY TJ, III eta].: Inter-leukin-1 receptor blockade attenuates the host inflam-matory response. Proc. Natl. Acad. ScL USA (1990) 87:4966–4970.
   Google Scholar
• DI SANTO E, SIRONI M, POZZI P et al.: Interleukin-10inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-113 production in the brain with-out affecting the activation of the hypothalamus-pitui-tary-adrenal axis. Neuroimmunomodulation (1995) 2:149–154.
   PubMed Web of Science ®Google Scholar
• BLACKWELL TS, CHRISTMAN JW: Sepsis and cytokines:current status. Br. J. Anaesth. (1996) 77:110–117.
   PubMed Web of Science ®Google Scholar
• • Good review of topic.
   Google Scholar
• FISHER CJJ, DHAINAUT JF, OPAL SM et al: Recombinanthuman interleukin-1 receptor antagonist in the treat-ment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA (1994) 271:1836.
   Google Scholar
• DINARELLO CA: Biologic basis for interleukin-1 disease.J. Am. Soc. HematoL (1996) 87:2095–2147.
   Google Scholar
• LEBSACK ME, PAUL CC, BLOEDOW DC et aL: Sc. IL-1receptor antagonist in patients with rheumatoid arthri-tis. Arthritis Rheum. (1991) 34:S67.
   Google Scholar
• ANTIN JH, WEINSTEIN HJ, GUINAN EC etal.: Recombinant human interleukin-1 receptor antagonist in the treat-ment of steroid-resistant graft-versus-host disease. Blood (1994) 84:1342.
   Google Scholar
• ROTHWELL NJ, HOPKINS SJ: Cytokines and the nervous system II: actions and mechanisms of action. Trends NeuroscL (1995) 18:130-136. Good review.
   Google Scholar
• ROTHWELL N: Functions and mechanism of IL-1 in thebrain. Trends Pharmacol Sci (1991) 12:430–435.
   PubMed Web of Science ®Google Scholar
• WANG XK, YUE T-L, BARONE FC et al.: Concomitantcortical expression of TNF -a and IL-1I3 mRNA following transient focal ischemia. Mot Chem. Neuropathol. (1994) 23:103–114.
   PubMedGoogle Scholar
• YAMASAKI Y, MATSUURA N, SHOZUHARA H eta].: Inter-leukin4 as a pathogenetic mediator of ischemic brain damage in rats. Stroke (1995) 26:676–681.
   Google Scholar
• RELTON JK ROTHWELL NJ: Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. (1992) 29:243-246 Inital report of IL-ra treatment effect.
   Google Scholar
• GARCIA JH, LIU KF, RELTON JK: Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Amer. J. Pathol (1995) 147:1477–1486.
   PubMed Web of Science ®Google Scholar
• LODDICK SA, ROTHWELL NJ: Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. (1996) 16(5):932–40.
   PubMed Web of Science ®Google Scholar
• BETZ AL, YANG GY, AND DAVIDSON BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. (1995) 15:547-551. Novel approach for delivery.
   Google Scholar
• RELTON J, MARTIN D, THOMPSON R, RUSSEL D: Peripheral administration of interleukin-1 receptor antago-nist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol (1996) 138:206-213. May have future clinical application.
   Google Scholar
• SHARIEF M, HENTGES R: Associationbetween TNF- a and disease progression in patients with multiple sclerosis. N. Engl. J. Med. (1991) 325:467–472.
   PubMed Web of Science ®Google Scholar
• LIU T, CLARK RK, MCDONNELL PC et al: Tumor necrosis factor expression in ischemic neurons. Stroke (1994) 25:1481–1488.
   PubMed Web of Science ®Google Scholar
• WANG X, YUE T, BARONE F: Concommitant cortical expression of TNF a mRNA following transient focal ischemia. MoL Chem. Neuropathol (1994) 23:103–114.
   PubMedGoogle Scholar
• CHAO C, EHRLICH L, PETERSON P: IL-1 and TNF synergistically mediate neurotoxicity. Brain Behav. Im-mun. (1995) 374:647–650.
   Google Scholar
• MEISTRELL M, COCKROFT KM, BOTCHKINA GI et al: TNF mediates brain damage in stroke. Stroke (1997) 28:255.
   Google Scholar
• HALLENBECK JM: Cytokines, macrophages, and leuko-cytes in brain ischemia. In: Advances in Stroke Manage-ment. Proceeding Highlights. Sherman DG (Ed.) (1996):5.
   Google Scholar
• BRUCE A, BOLING W, KINDY M eta].: Altered neuronal and microgjial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Meckine (1996) 2:788–794.
   Google Scholar
• ZHAI QH, FUTRELL N, CHEN FJ: Calcium bound cal-modulin is upregulated folowing TNF-a inhibition with antisense oligonucleotide after middle cerebral artery occlusion (MCA()) in the rat. Stroke (1997) 28:225.
   Google Scholar
• AKIRA S, TAGA T, KISHIMOTO T: Interleukin-6 in biology and medicine. Adv. Immunol (1993) 54:1–78.
   PubMed Web of Science ®Google Scholar
• MATHIESEN T, ANDERSSON B, LOFTENUS A, VON HOIST H: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J. Neurosurg. (1993) 78:562–567.
   PubMed Web of Science ®Google Scholar
• MERRILL JE, STROM SR, ELLISON GW, MYERS LW: In vitrostudy of mediators of inflammation in multiple sclero-sis. J. Clin. Immunol (1989) 9:84–96.
   PubMed Web of Science ®Google Scholar
• HIROHATA S, MIYAMOTO T: Elevated levels of inter-leukin-6 in cerebrospinal fluid from patients with sys-temic lupus erythematosus and central nervous system involvement. Arthritis Rheum. (1990) 33:644–649.
   PubMed Web of Science ®Google Scholar
• GIJBELS K, VANDAMMF J, PROOST P et al: Interleukin-6 production in the central nervous system during ex-perimental autoimmune encephalomyelitis. Eur. j hn-munol. (1990) 20:233–235.
   PubMed Web of Science ®Google Scholar
• WANG X, YUE T-L, YOUNG PR, BARONE FC, FEUERSTEIN
   Google Scholar
• •GZ: Expression of interleukin-6, c-fos, and zif268 mRNA in rat ischemic cortex. J. Cereb. Blood Flow Metab. (1995) 15:166-171. Initial report of IL-6 time course.
   Google Scholar
• TAUPIN V, TOULMOND S, SERRANO A, BENAVIDES J, ZAVALA F: Increase in IL-6, IL-1, and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro 54864, a peripheral type (p site) benzodiazepine liquid. J. Neuroimmunol (1993) 42:177–185.
   Google Scholar
• KUKIELKA GL, SMITH CW, MANNING AM eta].: Inductionof inter leukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory irjury. Stroke (1995) 92:1866–1875.
   Google Scholar
• CLARK W, LAUTEN J, COULL B, CHERRY N, WOODWARDW: ICAM-1 and IL-6changes in the hippocamp us follow-ing transient forebrain ischemia in the rat Soc. Neurosci. (1993) 19:1664.
   Google Scholar
• TOULMOND S,VIGE X, FAGE D, BENAVIDES J: Local infu-sion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. (1992) 144:49–52.
   PubMed Web of Science ®Google Scholar
• CAMPBELL ILABRAHAM CR, MASLIAH E et al.: Neurologicdisease induced in transgenic mice by ce rebraloverex-pression of interleukin-6. Proc. Natl. Acad. Sci. USA (1993) 90:10061–10065.
   PubMed Web of Science ®Google Scholar
• ROTH WELL NJ, RELTON JK: Involvement of cytokines inacute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. (1992) 17:217–227.
   Web of Science ®Google Scholar
• SELMAJ KW, FAROOQ M, NORTON WT, RAINE CS, BROS-NAN CF: Proliferation of astrocytes in vitro in response to cytokines. j Immunol. (1990) 144:129–135.
   PubMed Web of Science ®Google Scholar
• BEAMER NB, COULL BM, CLARK WM, HAZELJS, SILBERGER
   Google Scholar
• ••JR: Interleukin-6 and interleukin-1 receptor antagonistin acute stroke. Ann. Neurol. (1995) 37:800-804. Initial report of IL-lra levels post stroke.
   Google Scholar
• CLARK WM, HAZEL JS, BEAMER N, WYNN M, COULL B: Theinitial acute phase response predicts long-term stroke recovery. Stroke (1996) 27:186.
   Google Scholar
• ELNEIHOUM AM, FALKE P, AXELSSON L et aL: Leukocyteactivation detected by increased plasma levels of in-flammatory mediators in patients with ischemic cere-brovascular diseases. Stroke (1996) 27:1734–1738.
   PubMed Web of Science ®Google Scholar
• BEAMER N, COULL BM, SEXTON et al: Fibrinogen and thealbumin-globulin ratio in recurrent stroke. Stroke (1993) 24:1133–1139.
   PubMed Web of Science ®Google Scholar
• CLARK WM, COULL BM, BEAMER NB: Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease. Heart as. Stroke (1993) 2:503–506.
   PubMedGoogle Scholar
• COULL BM, BEAMER N, CLARK WM: Elevated plasma interleukin-6 in acute stroke. Stroke (1993) 24:183.
   Google Scholar
• ZHANG R, CHOPP M, JIANG N et al.: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cere-bral artery occlusion in the Wistar rat. Stroke (1995) 26:1438–1443.
   PubMed Web of Science ®Google Scholar
• ENLIMOMAB ACUTE STROKE TRIAL INVESTIGATORS: En-limomab acute stroke trial; final results. Neurology(1997) (In Press).
   Google Scholar
• FROHMAN EM, FROHMAN TC, DUSTIN ML et al.: The induction of intracellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-a, tumor necrosis factor-a, lymphotoxin, and interleukin-1: relelance to intracerebral antigen pres-entation. J. Neuroimmunol. (1989) 23:117–124.
   PubMed Web of Science ®Google Scholar
• POBER JS, GIMBRONE MA, LAPIERRE eta].: Overlapping patterns of activation of human endothelial cells by interlukin-1, tumor necrosis factor, and immune inter-feron. J. Immunol (1986) 137:1893–1896.
   Google Scholar
• YOUKER KA, SMITH CW, ANDERSON et al: Neutrophil adherence to isolated adult cardiac myocytes : induction by cardiac lymph collected during ischemia and rep er-fusion. J. Clin. Invest. (1992) 89:602–609.
   PubMed Web of Science ®Google Scholar
• CHUNG IY, BENVENISTE EN: TNF-a production by astro-cytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1. J. Immunol. (1990) 144:2999–3007.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN AP, PITHA PM, SHIN HS, SHIN ML: Productionof tumor necrosis factor and other cytokines by astro-cytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA (1989) 867:6348–6352.
   Web of Science ®Google Scholar
• CLARK WM, LAUTEN JD, BEAMER NB, COULL BM: Cytok-ine and superoxide production in clinical stroke. J. Stroke Cerebrovasc. Dis. (1995) 5:166–171.
   Google Scholar
• CLARK WM, LAUTEN JD, LESSOV N, WOODWARD W, COULL BM: Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol (1995) 26:213–230.
   PubMedGoogle Scholar